Affordable Access

deepdyve-link
Publisher Website

Identification of Serum Biomarkers for Ischemic Penumbra by iTRAQ-Based Quantitative Proteomics Analysis.

Authors
  • Pang, Xiao-Min1
  • Zhou, Xia1
  • Su, Sheng-You1
  • Chen, Chun-Yong1
  • Wei, Zhi-Xiao2
  • Tao, Yi-Feng3
  • Liu, Jing-Li1
  • 1 Department of Neurology, The First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China. , (China)
  • 2 Department of Nuclear Medicine, The First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China. , (China)
  • 3 Department of Laboratory, The Affiliated Tumor Hospital, Guangxi Medical University, Nanning, 530021, China. , (China)
Type
Published Article
Journal
PROTEOMICS - CLINICAL APPLICATIONS
Publisher
Wiley (John Wiley & Sons)
Publication Date
Sep 01, 2019
Volume
13
Issue
5
Identifiers
DOI: 10.1002/prca.201900009
PMID: 31099185
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Ischemic penumbra is the main therapeutic target for acute ischemic stroke. The aim in this study is to investigate the potential serum biomarkers of penumbra that could fulfill a complementary role in the acute stroke clinical decision-making process. An established focal cerebral ischemia model is applied in rats. Using isobaric tags for relative and absolute quantitation combined with liquid chromatography-tandem mass spectrometry, the global expression profiles of proteins in ischemic penumbra tissue and serum from rats subjected to different ischemic times are identified and quantified. Candidate biomarkers are screened out with bioinformatics analysis and further validated by western blotting. Herein, a total of 4568 proteins in the penumbra and 1915 proteins in the serum are identified. Two proteins related to the penumbra, RHOA, and CDC42, are screened out through an integrative analysis. The expression levels of RHOA and CDC42 in the penumbra and serum gradually increase synchronously with the prolonged ischemia time. The study provides the results of a proteomic analysis to identify serum biomarkers of the penumbra. Upregulation of RHOA and CDC42 may be useful for the early assessment of ischemic penumbra and could serve as potential serum biomarkers. © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Report this publication

Statistics

Seen <100 times